| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An historical overview over Pharmacovigilance
|
Fornasier, Giulia
|
|
2018
|
40 |
4 |
p. 744-747
|
artikel
|
| 2 |
An historical overview over Pharmacovigilance
|
Fornasier, Giulia
|
|
|
40 |
4 |
p. 744-747
|
artikel
|
| 3 |
Cardiovascular and gastrointestinal safety of selective cyclooxygenase-2 inhibitors: a case/non-case study
|
Martin Arias, Luis Hermenegildo
|
|
2018
|
40 |
4 |
p. 928-935
|
artikel
|
| 4 |
Community pharmacists’ knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey
|
Li, Raymond
|
|
2018
|
40 |
4 |
p. 878-889
|
artikel
|
| 5 |
Community pharmacists’ knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey
|
Li, Raymond
|
|
|
40 |
4 |
p. 878-889
|
artikel
|
| 6 |
Comparison of different methods for causality assessment of adverse drug reactions
|
Behera, Sapan Kumar
|
|
2018
|
40 |
4 |
p. 903-910
|
artikel
|
| 7 |
Current trends in pharmacovigilance: value and gaps of patient reporting
|
Inácio, Pedro
|
|
2018
|
40 |
4 |
p. 754-757
|
artikel
|
| 8 |
Current trends in pharmacovigilance: value and gaps of patient reporting
|
Inácio, Pedro
|
|
|
40 |
4 |
p. 754-757
|
artikel
|
| 9 |
Development and validation of an algorithm to identify drug-induced anaphylaxis in the Beijing Pharmacovigilance Database
|
Zhao, Ying
|
|
2018
|
40 |
4 |
p. 862-869
|
artikel
|
| 10 |
Development and validation of an algorithm to identify drug-induced anaphylaxis in the Beijing Pharmacovigilance Database
|
Zhao, Ying
|
|
|
40 |
4 |
p. 862-869
|
artikel
|
| 11 |
EU pharmacovigilance regulatory requirements of anticancer biosimilar monoclonal antibodies
|
Francescon, Sara
|
|
2018
|
40 |
4 |
p. 778-782
|
artikel
|
| 12 |
EU pharmacovigilance regulatory requirements of anticancer biosimilar monoclonal antibodies
|
Francescon, Sara
|
|
|
40 |
4 |
p. 778-782
|
artikel
|
| 13 |
Finasteride use during pregnancy and early neonatal outcome: a case report
|
AlSaad, Doua
|
|
2018
|
40 |
4 |
p. 803-805
|
artikel
|
| 14 |
Healthcare professionals’ knowledge, attitude and practice towards adverse drug reaction (ADR) reporting at the health center level in Ethiopia
|
Seid, Mohammed Assen
|
|
2018
|
40 |
4 |
p. 895-902
|
artikel
|
| 15 |
Healthcare professionals’ knowledge, attitude and practice towards adverse drug reaction (ADR) reporting at the health center level in Ethiopia
|
Seid, Mohammed Assen
|
|
|
40 |
4 |
p. 895-902
|
artikel
|
| 16 |
Is pharmacovigilance of biologicals cost-effective?
|
Claus, Barbara
|
|
2018
|
40 |
4 |
p. 787-789
|
artikel
|
| 17 |
Is pharmacovigilance of biologicals cost-effective?
|
Claus, Barbara
|
|
|
40 |
4 |
p. 787-789
|
artikel
|
| 18 |
Kidney function and use of nonsteroidal anti-inflammatory drugs among elderly people: a cross-sectional study on potential hazards for an at risk population
|
Modig, Sara
|
|
2018
|
40 |
4 |
p. 870-877
|
artikel
|
| 19 |
Learning the effects of psychotropic drugs during pregnancy using real-world safety data: a paradigm shift toward modern pharmacovigilance
|
Lupattelli, Angela
|
|
2018
|
40 |
4 |
p. 783-786
|
artikel
|
| 20 |
Learning the effects of psychotropic drugs during pregnancy using real-world safety data: a paradigm shift toward modern pharmacovigilance
|
Lupattelli, Angela
|
|
|
40 |
4 |
p. 783-786
|
artikel
|
| 21 |
Overview of pharmacovigilance practices at the largest academic healthcare system in the State of Qatar
|
Al Hail, Moza
|
|
2018
|
40 |
4 |
p. 769-774
|
artikel
|
| 22 |
Overview of this issue: pharmacovigilance, what is new?
|
Martin, Linda Gore
|
|
2018
|
40 |
4 |
p. 737-739
|
artikel
|
| 23 |
Overview of this issue: pharmacovigilance, what is new?
|
Martin, Linda Gore
|
|
|
40 |
4 |
p. 737-739
|
artikel
|
| 24 |
Pharmacovigilance in a rare disease: example of the VIGIAPATH program in pulmonary arterial hypertension
|
Chaumais, Marie-Camille
|
|
2018
|
40 |
4 |
p. 790-794
|
artikel
|
| 25 |
Pharmacovigilance in a rare disease: example of the VIGIAPATH program in pulmonary arterial hypertension
|
Chaumais, Marie-Camille
|
|
|
40 |
4 |
p. 790-794
|
artikel
|
| 26 |
Pharmacovigilance in China: development and challenges
|
Zhao, Ying
|
|
2018
|
40 |
4 |
p. 823-831
|
artikel
|
| 27 |
Pharmacovigilance in developing countries (part II): a path forward
|
Elshafie, Shaimaa
|
|
2018
|
40 |
4 |
p. 764-768
|
artikel
|
| 28 |
Pharmacovigilance in developing countries (part I): importance and challenges
|
Elshafie, Shaimaa
|
|
2017
|
40 |
4 |
p. 758-763
|
artikel
|
| 29 |
Pharmacovigilance in oncology
|
Baldo, Paolo
|
|
2018
|
40 |
4 |
p. 832-841
|
artikel
|
| 30 |
Pharmacovigilance in oncology
|
Baldo, Paolo
|
|
|
40 |
4 |
p. 832-841
|
artikel
|
| 31 |
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
|
Baldo, Paolo
|
|
2018
|
40 |
4 |
p. 748-753
|
artikel
|
| 32 |
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
|
Baldo, Paolo
|
|
|
40 |
4 |
p. 748-753
|
artikel
|
| 33 |
Potential negative impact of informing patients about medication side effects: a systematic review
|
Jose, Jimmy
|
|
2018
|
40 |
4 |
p. 806-822
|
artikel
|
| 34 |
Potential negative impact of informing patients about medication side effects: a systematic review
|
Jose, Jimmy
|
|
|
40 |
4 |
p. 806-822
|
artikel
|
| 35 |
Prevalence and characteristics of hospital inpatients with reported fluoroquinolone allergy
|
Wall, Geoffrey C.
|
|
2018
|
40 |
4 |
p. 890-894
|
artikel
|
| 36 |
Prevalence and characteristics of hospital inpatients with reported fluoroquinolone allergy
|
Wall, Geoffrey C.
|
|
|
40 |
4 |
p. 890-894
|
artikel
|
| 37 |
Reporting adverse drug reactions: contribution, knowledge and perception of German pharmacy professionals
|
Laven, Anna
|
|
2018
|
40 |
4 |
p. 842-851
|
artikel
|
| 38 |
Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance
|
Fornasier, G.
|
|
2018
|
40 |
4 |
p. 795-802
|
artikel
|
| 39 |
Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance
|
Fornasier, G.
|
|
|
40 |
4 |
p. 795-802
|
artikel
|
| 40 |
The role and strategy of ISoP in global pharmacovigilance
|
Olsson, Sten
|
|
2018
|
40 |
4 |
p. 740-743
|
artikel
|
| 41 |
The role and strategy of ISoP in global pharmacovigilance
|
Olsson, Sten
|
|
|
40 |
4 |
p. 740-743
|
artikel
|
| 42 |
The role of the suspicious renal pharmacist in identifying unusual adverse drug reactions—why this is not a small problem
|
Coulter, Carolyn Vera
|
|
2018
|
40 |
4 |
p. 775-777
|
artikel
|
| 43 |
Traditional Chinese medicine and drug-induced anaphylaxis: data from the Beijing pharmacovigilance database
|
Li, Xiaotong
|
|
2018
|
40 |
4 |
p. 921-927
|
artikel
|
| 44 |
Traditional Chinese medicine and drug-induced anaphylaxis: data from the Beijing pharmacovigilance database
|
Li, Xiaotong
|
|
|
40 |
4 |
p. 921-927
|
artikel
|
| 45 |
Trends in reporting drug-associated liver injuries in Taiwan: a focus on amiodarone
|
Ye, Jun-Hong
|
|
2018
|
40 |
4 |
p. 911-920
|
artikel
|
| 46 |
Using a cancer registry to capture signals of adverse events following immune and targeted therapy for melanoma
|
Aguiar, João P.
|
|
2018
|
40 |
4 |
p. 852-861
|
artikel
|
| 47 |
Using a cancer registry to capture signals of adverse events following immune and targeted therapy for melanoma
|
Aguiar, João P.
|
|
|
40 |
4 |
p. 852-861
|
artikel
|
Tijdschrift beschrijving